Natural Products with Toll-Like Receptor 4 Antagonist Activity

被引:56
|
作者
Molteni, Monica [1 ]
Bosi, Annalisa [1 ]
Rossetti, Carlo [1 ]
机构
[1] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via Dunant 3, I-21100 Varese, Italy
关键词
D O I
10.1155/2018/2859135
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-Like Receptors (TLRs) are the innate immunity receptors that play an activating role when interacting with molecules released by bacteria and viruses (PAMPs, pathogen-associated molecular patterns) or with molecules released by injured cells and tissues (DAMPs, danger-associated molecular patterns). TLR triggering leads to the induction of proinflammatory cytokines and chemokines, driving the activation of both innate and adaptive immunity. In particular, Toll-Like Receptor 4 (TLR4) has been described to be involved in the inflammatory processes observed in several pathologies (such as ischemia/reperfusion injury, neuropathic pain, neurodegenerative diseases, and cancer). Molecules obtained by natural sources have been discovered to exert an anti-inflammatory action by targeting TLR4 activation pathways. This review focuses on TLR4 antagonists obtained from bacteria, cyanobacteria, and plants.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105
    Divanovic, S
    Trompette, A
    Atabani, SF
    Madan, R
    Golenbock, DT
    Visintin, A
    Finberg, RW
    Tarakhovsky, A
    Vogel, SN
    Belkaid, Y
    Kurt-Jones, EA
    Karp, CL
    NATURE IMMUNOLOGY, 2005, 6 (06) : 571 - 578
  • [32] Role of toll-like receptor 2 and toll-like receptor 4 in postischemic coronary endothelial dysfunction in mice
    Favre, J
    Musette, P
    Henry, JP
    Thuillez, C
    Richard, V
    CIRCULATION, 2004, 110 (17) : 34 - 34
  • [33] Toll-like receptor 3 mediates a more potent antiviral response than toll-like receptor 4
    Doyle, SE
    O'Connell, R
    Vaidya, SA
    Chow, EK
    Yee, K
    Cheng, GH
    JOURNAL OF IMMUNOLOGY, 2003, 170 (07): : 3565 - 3571
  • [34] Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
    Guriec, Nathalie
    Bussy, Frederick
    Gouin, Christelle
    Mathiaud, Olivier
    Quero, Benoit
    Le Goff, Matthieu
    Collen, Pi Nyvall
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [35] Function and Phenotype of Microglia Are Determined by Toll-Like Receptor 2/Toll-Like Receptor 4 Activation Sequence
    Li, Weixin
    Gao, Guodong
    Guo, Qingdong
    Jia, Dong
    Wang, Julei
    Wang, Xuelian
    He, Shiming
    Liang, Qinchuan
    DNA AND CELL BIOLOGY, 2009, 28 (10) : 493 - 499
  • [36] Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema
    Weidinger, Stephan
    Novak, Natalija
    Klopp, Norman
    Baurecht, Hansjoerg
    Wagenpfeil, Stefan
    Rummler, Lars
    Ring, Johannes
    Behrendt, Heidrun
    Illig, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (01) : 277 - 279
  • [37] Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood
    De Wit, D
    Tonon, S
    Olislagers, V
    Goriely, S
    Boutriaux, M
    Goldman, M
    Willems, F
    JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) : 277 - 281
  • [38] Toll-Like Receptor 2 or Toll-Like Receptor 4 Deficiency Does Not Modify Lupus in MRLlpr Mice
    Freeley, Simon J.
    Giorgini, Angela
    Tulone, Calogero
    Popat, Reena J.
    Horsfield, Catherine
    Robson, Michael G.
    PLOS ONE, 2013, 8 (09):
  • [39] Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor4 Antagonist Activity of a Synthetic Glycolipid
    Facchini, Fabio A.
    Coelho, Helena
    Sestito, Stefania E.
    Delgado, Sandra
    Minotti, Alberto
    Andreu, David
    Jimenez-Barbero, Jesus
    Peri, Francesco
    CHEMMEDCHEM, 2018, 13 (03) : 280 - 287
  • [40] Suppressive effects of toll-like receptor 2, toll-like receptor 4, and toll-like receptor 7 on protective responses to Mycobacterium bovis BCG from epithelial cells
    Singh, Aarti
    Singh, Akshita
    Saraswati, Shakuntala Surender Kumar
    Rana, Ankush Kumar
    Singh, Aayushi
    Verma, Chaitenya
    Sinha, Vishal
    Kalra, Kanika
    Natarajan, Krishnamurthy
    MICROBES AND INFECTION, 2025, 27 (02)